Pharmesis International Ltd (SGX:BFK) Share Price

Company Profile

Business description
Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its operating segments are Western drugs/TCH Procurement, which are chemically formulated drugs and are marketed under the Kinna brand; TCM-formulated drugs/IP rental, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution, which derives maximum revenue, refers to agency products and internally manufactured products which are marketed through the distribution arm. The company derives revenue from the sale of medicines to domestic customers in China.
Contact
5 Kallang Sector
No. 03-02
Singapore349279
SGP
T: +65 68460766
https://www.pharmesis.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees

Recommended

International expansion is a distraction from valuable local business.

Roy Van Keulen | 14 May 2026

The chipmaker’s IPO priced at $185, well above its initial range, and opened trading at an eye-popping $350.

Jacob Robbins | 14 May 2026

How the most traded shares in April stack up against our analysts views.

Tyger Fitzpatrick | 14 May 2026

Index	Last price	Change	% Change
All Ordinaries	8,870.60	46.70	-0.52%
CAC 40	7,953.99	128.28	-1.59%
DAX 40	23,974.48	481.78	-1.97%
Dow JONES (US)	50,063.46	370.26	0.75%
FTSE 100	10,180.61	192.32	-1.85%
HKSE	25,962.73	426.31	-1.62%
NASDAQ	26,635.22	232.88	0.88%
Nikkei 225	61,409.29	1,244.76	-1.99%
NZX 50 Index	12,965.01	60.06	-0.46%
S&P 500	7,501.24	0.00	0.00%
S&P/ASX 200	8,630.80	42.70	-0.49%
SSE Composite Index	4,135.39	42.53	-1.02%